Stemmera公司位于美国加州，主要生产干细胞相关产品，包括检测试剂盒、培养基、抗体、缓冲液，还包括用于干细胞研究的细胞系。

Stemmera Inc is a privately owned biotechnology company located in Bay Area, California that focus in developing innovative technology and application solution for stem cell research. Our products include kit, culture medium, reagents, antibodies, buffer and solution, cell lines that are convenient tools used in stem cell research.

Stemmera公司主要产品：

（1）Kit

Alkaline Phosphatase (AP) Detection Kit (Ready-to-use)-Blue

Alkaline Phosphatase (AP) Detection Kit (Ready-to-use)-Red

Human Fibroblast (hFIB) Reprogramming Kit

Human Blood Cell (hBLD) Reprogramming Kit

（2）Media

Human ESCs/iPSCs Serum-/ Feeder-Free Medium (hStemSFM)

Human ESCs/iPSCs Xeno-Free Medium (hStemXFM)

Human Fibroblast (hFIB) Reprogramming Medium

Human Blood Cell (hBLD) Reprogramming Medium

Fibroblast Growth Medium

（3）Buffer & Solutions

Non-Enzymatic Cell Dissociation Solution (1X)

Serum-Free Cryopreservation Solution for Human ESCs/iPSCs

0.2% Gelatin

0.1% Gelatin

Universal Cryopreservation Solution

Blood Cell Cryopreservation Solution (1x)

Cell Fixation Solution (4% Paraformaldehyde, PFA)

Cell Fixation Solution (10% Formalin)

Metaphase Arrest Solution (10 μg/ml, 10X)

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Fabgennix品牌。

Fabgennix的产品列表不断更新，包括一抗、二抗、试剂、试剂盒、多肽和阳性对照。Fabgennix产品应用范围，涉及领域包括：癌症研究、细胞生物学、免疫学、微生物、激酶、离子通道和信号转导、干细胞、代谢、凝血、信号转导、内分泌研究、神经科学。所有FabGennix一抗均在经过验证，保证对其靶标具有高亲和力。在试剂盒和试剂方面，FabGennix公司开发了几种广为发表的试剂盒和试剂，以帮助进行蛋白质表征。

艾美捷科技特约代理BioPorto Diagnostics A/S公司产品。

BioPorto Diagnostics A/S公司成立于2001年，是丹麦一家专门生产抗体和基于抗体的各种生物产品的公司。BioPorto拥有Bioporto Diagnostics和Antibodyshop两个品牌，分别侧重于诊断试剂盒和抗体产品。在30多个国家有代理商，产品销售网络遍布全球，99%以上为出口销售。BioPorto Diagnostics旗下产品主要为几种临床快速诊断试剂盒，包括诊断早期急性肾损伤的NGAL ELISA kit，Gc-globulin ELISA kit ，评估原发性免疫缺陷的MBL Oligomer ELISA kit，同时还有相关其他种属的科研用试剂盒和抗原抗体。其最新推出的产品有检测人体血浆中的活性蛋白C-蛋白C抑制物(APC-PCI)复合物的APC-PCI ELISA kit，高纯度人IgE单克隆抗体，以及Glucagon-like peptide-1和Exendin-4相关的单抗。

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.